Key result
The ACTN3 RR genotype was significantly more common in Polish rowers compared to controls (53.8% vs 36.3%, p=0.01), contradicting the hypothesis that the 577X allele benefits endurance rowing.
Why the study?
Is the ACTN3 R577X polymorphism associated with athletic performance in Polish rowers?
Case-Control (n=284)
Is the ACTN3 R577X polymorphism associated with athletic performance in Polish rowers?
Absolute Event Rate: 53.8% vs 36.3%
p-value: p=0.01
The ACTN3 RX or RR genotypes appear to be associated with elite rowing status in Polish athletes, contrary to the hypothesis that the 577X allele benefits endurance performance.
RR genotype may associate with elite Polish rowing; challenges 577X endurance hypothesis but leaves generalizability open.
The first evidence that a mononucleotide difference in DNA sequence was associated with power ability referred to the R577X polymorphism of the ACTN3 gene, where translation (C > T) at nucleotide position 1747 in the ACTN3 coding sequence converts an arginine (R) to a stop codon (X) at residue 577. In the present study, DNA polymorphism derived from the ACTN3 gene was studied in Polish rowers to examine the hypothesis that the ACTN3 genotype is associated with athletic performance. The study involved 80 male Polish rowers of a nationally competitive standard and 204 unrelated volunteers for controls. Genotype distribution among the whole group of athletes (53.8% RR, 38.8% RX, 7.4 XX% DD) was significantly different to that among controls (36.3% RR, 46.1% RX, 17.6%; p = 0.01). When only elite rowers were considered, p value for genotype distribution (56.8% RR, 37.8% RX, 5.4% XX) was 0.03. The genotype distribution among nonelite rowers (52.2% RR, 39.1% RX, 8.7% XX) was not significantly different to that among controls (p = 0.09). A significant excess of the 577R allele was noted in the whole cohort of rowers (73.11%, p = 0.002). This trend was similar when comparing with the controls (59.3%) the allele frequency in elite rowers (75.7%, p = 0.007) and nonelite rowers (71.7%, p = 0.026). In conclusion, our results are contrary to the hypothesis that the ACTN3 577X allele may have some beneficial effect on endurance performance in rowing. On the contrary, the ACTN3 RX or RR genotypes seem to be a requirement for being an elite rower, therefore, identification of ACTN3 polymorphism as a genetic marker for rowing talent should be interpreted with great caution.
No takes yet. Share an insight, caveat, or question.
Cięszczyk et al. (2012) conducted a case-control in Athletic performance (rowing) (n=284). ACTN3 R577X polymorphism vs. Unrelated volunteer controls was evaluated on ACTN3 RR genotype frequency (p=0.01). The ACTN3 RR genotype was significantly more common in Polish rowers compared to controls (53.8% vs 36.3%, p=0.01), contradicting the hypothesis that the 577X allele benefits endurance rowing.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: